PREFACE

References

1. Wal A. Rawat A. Verma R. Rasheed A. Panigrahy U.P. Das A. Gasmi A. Therapeutic targets for myocardial fibrosis: a comprehensive review of current and emerging approaches. 2026 21 1
2. Duy T.N. Oanh O.N. Trung K.N. Ha K.L. Kim H.H.T. Lien H.N.T. Van D.D. CYP2C19 genetic variants associated with clopidogrel resistance and major adverse cardiovascular events in vietnamese patients undergoing percutaneous coronary intervention 2026 21 1
3. Aghamirzadeh M. Ahmadi F. Jorfi F. Akiash N. Abbaspour S. Adel S.M.H. Mohammadi S. Impacts of sacubitril-valsartan versus valsartan on Left ventricular remodeling and cardiac function in patients with ischemic heart failure and reduced ejection fraction: A randomized double-blinded controlled trial. 2026 21 1
4. Puri D. Verma B. Bhardwaj H. Jangde R.K. Updated review of current therapeutic approaches for the management of sickle cell disease. 2026 21 1
   [Google Scholar]
5. Kachhwaha A. Singh S. Singh N. Bahl C. Nath U.K. Acute non-promyelocytic leukemia with complex karyotype and novel t (15;17) (q21;p11.2)/B2M: RARA fusion: A case report 2026 21 1
6. Singh J. Dinkar A. Kumar N. Kumar K. Ranjan R. Atam I. Spontaneous lingual bleeding and intracerebral hemorrhage in a young adult with immune thrombocytopenia (ITP): A rare case report and brief recent update on treatment 2026 21 1